BACKGROUND: Elderly patients with stage I NSCLC who undergo surgical resection are at
high risk of treatment-related toxicity. Stereotactic body radiation therapy (SBRT) may …

Background: Surgical resection is the treatment of first choice for patients with stage I-II non-
small cell lung cancer (NSCLC). However, stereotactic body radiotherapy (SBRT) has been …

Objectives It is unclear whether elderly patients face an increased risk of complications
following stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung …

Background The purpose of this study was to describe our clinical experience using
stereotactic body radiation therapy (SBRT) to treat medically inoperable stage I non–small …

As the incidence of stage I non-small cell lung cancer (NSCLC) increases among
octogenarians and only selected patients are surgical candidates, an alternative treatment is …

BACKGROUND: The number of patients aged≥ 75 years who present with a stage I
nonsmall cell lung cancer (NSCLC) is increasing. Elderly patients often have significant …

Purpose Stereotactic body radiotherapy (SBRT) for stage I non–small-cell lung cancer
(NSCLC) is associated with high local control rates. The impact of introducing SBRT in …

Background Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC)
is primarily a treatment option for medically inoperable patients, who are often elderly …

Background The optimal treatment for elderly patients with early-stage non-small cell lung
cancer (NSCLC) remains inconclusive. Previous studies have shown that stereotactic body …

BACKGROUND Although surgery is the standard treatment for early‐stage non–small cell
lung cancer (NSCLC), stereotactic body radiotherapy (SBRT) has been disseminated as an …